Showing results (1-10 of 139) with videos related to
Sort By:
Pageof 14
Circulation. Cardiovascular Quality and Outcomes|August 12, 2017
Bayesian Analysis: A Practical Approach to Interpret Clinical Trials and Create Clinical Practice GuidelinesJohn A Bittl, Yulei HeCirculation. Cardiovascular Interventions|December 9, 2015
Factors Affecting Bleeding and Stent Thrombosis in Clinical Trials Comparing Bivalirudin With Heparin During Percutaneous Coronary InterventionJohn A Bittl, Yulei He, Christopher D Lang, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 27, 2015
Outcomes after multivessel or culprit-Vessel intervention for ST-elevation myocardial infarction in patients with multivessel coronary disease: a Bayesian cross-design meta-analysisJohn A Bittl, Jacqueline E Tamis-Holland, Christopher D Lang, et al.Circulation|May 16, 2013
Bayesian methods affirm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main coronary artery diseaseJohn A Bittl, Yulei He, Alice K Jacobs, et al.JACC. Cardiovascular Interventions|December 21, 2019
Bayes Factor Meta-Analysis of the Mortality Claim for Peripheral Paclitaxel-Eluting DevicesJohn A Bittl, Yulei He, Usman Baber, et al.Progress in Cardiovascular Diseases|February 15, 2021
Dialysis access intervention: Techniques for the interventional cardiologistJohn A BittlJACC. Cardiovascular Interventions|February 5, 2010
Catheter interventions for hemodialysis fistulas and graftsJohn A BittlCatheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 15, 2017
Bivalirudin or heparin for radial access?John A BittlCatheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 18, 2009
Venous rupture during percutaneous treatment of hemodialysis fistulas and graftsJohn A BittlJournal of the American Heart Association|December 21, 2018
Using Ticagrelor to Prevent Recurrent Type 1 and Type 2 Myocardial Infarctions: Boon or Bane?John A BittlPageof 14